Experimental injection may one day reduce need for mastectomies

01/1/2014 | MedicalDaily.com

Harvard University researchers were able to block HoxA1, a specific gene strongly associated with breast cancer, when they injected mice with an RNA agent. The treatment could potentially block the effects of genes that predispose women to certain breast cancers and reduce or eliminate the need for such invasive treatments as mastectomies. The findings appeared in the journal Science Translational Medicine.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT